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Background: Essential tremor (ET) is one of the commonest movement disorders though the prevalence varies
globally. There is paucity of data on ET prevalence in sub-Saharan Africa. The study aimed to determine the
prevalence of ET in a Nigerian community.
Methods: This door-to-door survey was conducted in two stages. In Stage 1, 3000 randomly selected residents of
an urban centre in Lagos, Nigeria, were screened using a questionnaire to detect symptoms of movement disorder.
234 participants who responded positively regarding presence of tremors were rescreened using an ET-specific
questionnaire, a face-to-face interview and neurological examination. Diagnosis of ET was based on the Movement
Disorders Society (MDS) consensus diagnostic criteria for ET.
Results: Of the 3000 participants, forty responded positively to the ET screening questionnaire, of which 36
(19 females and 17 males) had a final diagnosis of ET, giving a crude prevalence of 12 per 1000 (95% CI = 8.1- 15.9).
Gender specific prevalence was 10.3 /1000 in males and 14.3/1000 in females. Age specific prevalence increased
with advancing age in both sexes. Age adjusted prevalence (WHO New world population) was 23.8 per 1000.
Conclusions: We documented a high prevalence of ET in this study, with typical increasing prevalence with
advancing age as previously reported in other populations.
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Essential tremor (ET) is the most common pathologic
tremor in humans and one of the most frequently
encountered movement disorders in clinical practice.
The world-wide prevalence of ET ranges from 4.9 – 39.2
per 1000 across different populations, and is highest in
persons above 60 years of age (13.0 – 50.5 per 1000) [1].
Traditionally viewed as a single disease entity, ET is now
considered to be a family of distinct diseases based on
the clinical phenotypic variability, including occurrence
of other tremors, and additional motor and non-motor
features (mainly cognitive, somatosensory and psychi-
atric) [2].
ET is characterized by an action (postural or kinetic)
tremor that is clearly visible, continuous, bilateral and
usually symmetrical. The tremor often involves the arms,
head and/or voice, with occasional affectation of the* Correspondence: njide_okubadejo@yahoo.com
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distribution, and reproduction in any mediumlegs, chin, and trunk [3]. The prevalence of ET increases
with age and appears to be higher in Caucasians than
African Americans even within the same geographic
location [4]. ET occurs at all ages although there is a
bimodal peak in the second and sixth decades [5]. Dis-
ease progression is slow, occurring over several years
although the factors contributing to its progression
are unknown.
Other motor features may be encountered, particularly
with advancing disease, and include gait ataxia, postural
instability, and eye movement abnormalities [6,7]. These
features mimic cerebellar disorders and lend credence to
the hypothesis that the pathogenesis of ET is related
to cerebellar dysfunction. Non-motor accompaniments
such as cognitive impairment particularly executive dys-
function [8], sensory abnormalities such as mild olfactory
dysfunction [9], hearing impairment [10], mood disturb-
ance – anxiety and depression [11], and social phobia [12]
have also been reported in association with ET.
ET is associated with significant functional disability
particularly in persons with an upper limb tremor [13].tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
1. Do you have shaking or tremor that you cannot control?
2. Do other people tell that you have a tremor or are shaking?
3. Has a doctor diagnosed you as having tremors?
4. Do you often have shaking in your hands or arms that you cannot
control?
5. Does your head often shake uncontrollably?
6. Do you often have shaking anywhere else in your body (legs,
voice, mouth, chin)?
7. Does your voice often tremble when you talk?
8. Does your hand tremble or shake when you hold a pen to write?
9. Does your hand shake when you hold a fork, spoon or knife?
10. Does your hand shake when you drink or pour from a cup or a
glass?
11. Does shaking or tremor make you spill when drinking from a cup
or eating with a spoon?
12. Does your hand shake or tremble uncontrollably when you
button your shirt?
Figure 1 List of questions in 12-item ET specific questionnaire
used in stage 2 (case ascertainment).
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turely and 60% do not apply for work or promotion
because of uncontrollable tremors [14]. Clinical hetero-
geneity in the severity of ET contributes to a diagnostic
gap, with patients only tending to present in the event
that disease progression interferes with activities of daily
living or results in social or functional impairments.
Thus, the prevalence of ET derived from hospital-based
studies will reflect an under ascertainment. There are
few community-based prevalence figures for ET in
Africa. In a community based study of neurological dis-
orders in Nigeria by Osuntokun et al. in 1982 [15],
the crude prevalence of ET was reported as 10/100,000
while Haimanot et al. from Ethiopia reported a crude
prevalence of 5/100,000 [16]. More recently, Dotchin et al.
(2008) reported an ET prevalence of 82/100,000 from a
community based study in Tanzania (east Africa) [17].
The present study was designed to determine ET
prevalence in Nigerians from a community-based meth-
odologically sound perspective, providing a credible basis
for comparison with other populations.
Methods
The study employed a multi-staged design incorporating
a population-based door to door screening and a face-
to-face interview. The population survey was conducted
in Surulere Local Government Area (LGA), Lagos State,
Nigeria between March and September 2008. The study
was tagged onto a prospective community based study
on the epidemiology of neurological disorders in Lagos
State, Nigeria [18] by taking advantage of the research
funding and infrastructure for the study. Surulere LGA
is a mixed-income urban community in Lagos State,
with an estimated population of 750,000 (based on data
from the National Population Commission of Nigeria),
comprised of approximately 750 enumeration areas
(EAs), with each EA constituting of 1000 persons. 2% of
the enumeration areas (estimated population of 15000)
were previously randomly selected (based on a com-
puterized random-selection program) and were deli-
neated in the Epidemiology of Stroke in Lagos (EPISIL)
study [18].
Ethical approval for this study was obtained from the
Health Research Ethics Committee of the Lagos University
teaching Hospital. Written informed consent was obtained
from all study participants. The study team was comprised
of 4 neurologists and 5 trained field assistants. The study
was conducted in 2 stages.
Stage 1 - Screening for movement disorders
In the 1st stage of this study, 20% (3000 persons) of the
original population used for the EPISIL study were ran-
domly selected and rescreened for the presence of move-
ment disorders using a movement disorder screeningquestionnaire developed for the purpose of the study.
3 screening questions were used to detect potential cases
of movement disorders;
a) Do your hands and/or arms shake?
b)Have you noticed you have become slower when
walking?
c) Do you shuffle your feet (drag your feet on the floor)
or take small steps when you walk?
Response options were “yes”, “no”, “don’t know” and
“didn’t respond”. A total of 234 participants responded
positively to the question regarding presence of tremors
in the screening questionnaire and were screened in
stage 2 of this study.
Stage 2 - ET screening and case ascertainment
In the second stage, all 234 participants who screened
positive for tremor in Stage 1 were rescreened by a neur-
ologist in the participant’s home, using a 12-item ET
specific questionnaire (Figure 1) and a questionnaire to
document their demographic and historical data. In
addition, a specific face-to-face interview was conducted
to differentiate between ET, other tremors and parkin-
sonism. Specific aspects of this specific interview
included questioning about difficulty rising from a low
chair, change in handwriting, softening of the voice, poor
Okubadejo et al. BMC Neurology 2012, 12:110 Page 3 of 7
http://www.biomedcentral.com/1471-2377/12/110balance, mouth hanging open and drooling of saliva, dif-
ficulty doing tasks like buttoning a shirt or using a
screwdriver, walking with a stooped posture and feet
being glued to the floor. All the participants in stage 2
also had a neurological examination conducted by a
study neurologist to further ascertain the clinical diagno-
sis of ET. The diagnostic criteria for ET were based on
the Movement Disorders Society (MDS) consensus diag-
nostic criteria [19]. ET was diagnosed in the presence of
both major criteria (bilateral action tremor of the hands
and forearms or isolated head tremor without dystonia)
in the absence of any other neurological signs. Partici-
pants with parkinsonism, cerebellar (intention) tremor,
drug-induced tremors, dystonia and tremors in the pres-
ence of features of hyperthyroidism were all excluded
from the study.
Severity of ET was assessed using an essential tremor
scale in which tremor was rated as 0 (absent), 1 (slight,
infrequent, mild tremor, writing and drawing of spiral
minimally impaired), 2 (moderate – bothersome, writing
and drawing of spiral moderately impaired), 3 (severe –
writing and drawing severely impaired; interferes with
many activities such as drinking liquids), or 4 – (mark-
edly severe – interferes with most activities) [20].Performance of the ET instrument (sensitivity, specificity,
and number needed to diagnose)
The sensitivity and specificity of the ET screening instru-
ment was determined using the formula sensitivity = true
positive/ true positive + false negative. The specificity
was calculated as being equal to true negative/true
negative + false positive.
Of the 40 who screened positive to the ET specific
questionnaire in stage 2, 36 were finally diagnosed as ET
(true positive), while 4 were not ET (false positive).
These four were excluded based on the following:Table 1 Population distribution, age-specific and age–adjuste
Age stratification Population (%) Gender Num
ETMale (%) Female (%)
Below 15 years 706 (23.5) 389 (13.0) 317 (10.5)
15 to 24 years 832 (27.7) 452 (15.1) 380 (12.6)
25 to 34 years 594 (19.8) 333 (11.1) 261 (8.7)
35 to 44 years 411 (13.7) 228 (7.6) 183 (6.1)
45 to 54 years 278 (9.3) 161 (5.4) 117 (3.9)
55 to 64 years 110 (3.7) 63 (2.1) 47 (1.6)
65 to 74 years 43 (1.4) 25 (0.8) 18 (0.6)
75 to 84 years 19 (0.6) 13 (0.4) 6 (0.2)
85 years and older 7 (.2) 4 (0.1) 3 (0.1)
All ages 3000 1668 (55.6) 1332 (44.4)Parkinson’s disease – 1, drug induced parkinsonism – 1,
drug induced tremor (salbutamol tablets for bronchial
asthma) – 1, and hyperthyroidism – 1. The 80 non ET
participants used to assess the performance of the ET
specific instrument were randomly selected from the
non ET following rescreening with the ET specific in-
strument and face to face examination. All did not have
ET based on the diagnostic criteria (including hand
tremor and head tremor), resulting in false negative of 0
and true negative of 80.
The total numbers in each category were thus: true
positive – 36, true negative – 80, false positive – 4, and
false negative – 0. Thus, the sensitivity of the ET screen-
ing questionnaire was 100%, and the specificity was
95.2%. In addition, the utility of the screening instru-
ment was further evaluated using number needed to
diagnose (NND) defined as the number of patients that
need to be tested to give one correct positive test (You-
den’s J = 1/[sensitivity – (1-specificity)] [21]. The NND
ET using the ET specific questionnaire was calculated as
1.05 (95% CI 1.05 – 1.22) using Youden’s J.
Data was analysed using the Statistical Package for So-
cial Sciences (SPSS) version 16. The crude prevalence
rate was determined by the total number of ET cases
divided by the total population screened (3000) and
reported as number of ET pr 1000 population. The age
adjusted prevalence rate of ET in this study was deter-
mined using the World Health Organization (WHO)
new world population standard [22].Results
Demographic profile of the study population
A total of 3000 persons were screened for ET, comprised
of 55.6% male (1668/3000) and 44.4% female (1332/
3000). Age (by mid-decade strata) and gender distribu-
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ticipant evaluation and case ascertainment.
Prevalence rates (crude and age adjusted) of essential
tremor
A total of 36 of the 3000 screened participants were diag-
nosed as having ET, resulting in a crude prevalence rate of
12/1000 population (95% Confidence Interval – CI) =8.1 –
15.9) (Table 1). The crude prevalence rates by gender were
10.2/1000 (i.e. 17/1668) in males and 14.3/1000 (19/1332)
in females. The gender difference in crude prevalence
was not statistically significant (relative risk 0.71, 95% CI
0.37 – 1.37, P = 0.40). Prevalence increased with advancing
age from no cases documented in those below 15 years (0)
and the highest rates in those between 75 and 84 years
(473.7/1000). Figure 3 shows this increase in the preva-
lence of ET with advancing age in both sexes. ET preva-
lence was age standardized using the World HealthStage 1: Initial scr
Total number of pa
Screened positive for presence of tremors
N=234
Stage 2: Case ascertainment
Screened in 2 steps 
N = 234
Step 1: 12- item ET specific questionnaire












Figure 2 Flow chart of participant evaluation and case ascertainmentOrganization (WHO) New World Population standards as
shown in Table 1 with a resultant age-adjusted prevalence
of 23.8/1000.
Demographic and clinical characteristics of persons with
essential tremor
The mean age at study of ET cases was 59.6 ± 22.6
years while the mean age at onset of tremors was
44.6± 18.5 years. The male to female ratio was 1:1.1. The
mean duration of ET was 4.9 ± 3.8 years while there was a
positive family history of ET in 13 (36.1%) of the 36 ET
cases. The most common initial symptom of ET was hand
tremor in the 36 (100%) ET cases.
In 44.4% (16 of 36) the site of onset was the right arm,
while 22.2% (8 of 36) started in the left arm and 10 of
36 (27.8%) had tremor onset in both upper limbs. The
remaining 2 cases (5.6%) could not recollect the site of
onset of ET. All 36 ET (100%) had bilateral tremors ateeninginterview
rticipants = 3000
Screened negative for presence of tremors
(and thus excluded from study)
N = 2766
1 outcome




agnosed as ET 
 = 36
 other diagnoses N = 4
s disease=1; drug- induced 
; drug-induced tremor 
1; hyperthyroidism=1
.
Figure 3 Prevalence of essential tremor per 1,000 population by age strata and gender.
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lower limb tremors.
All ET (100%) had postural tremors while 32 of 36
(88.9%) had kinetic tremors in addition to postural tre-
mors. Only 1 out of 36 (2.8%) with ET had an intention
tremor in addition to the postural tremor (with no other
features of cerebellar disease). None of the ET cases had
a rest tremor. Tremor severity was mild in the majority
of cases (28 i.e. 77.8%), moderate in 7 (19.4%) and severe
in 1(2.8%). Only 1 (2.8%) of the ET cases was on treat-
ment at the time of this study (and the only one with a
prior diagnosis of ET). 35 of the cases were newly diag-
nosed as a result of the study.
Discussion
This study utilized a robust methodology to determine
the prevalence of essential tremor in an urban black
African community in sub-Saharan Africa, where data
are sparse regarding the epidemiology of movement dis-
orders including ET. The sample size was modest, and
was dictated by financial and logistic constraints, as well
as a commitment to allow complete case ascertainment
using a manageable population size. The study instru-
ment for screening for ET had several advantages, in
that the sensitivity (100%), specificity (95.2%) and num-
ber needed to diagnose ET (1.05) significantly improved
the likelihood of complete ascertainment of cases of ET
in the participants. Furthermore, face-to-face neuro-
logical diagnosis remains the clinical gold standard for
the diagnosis of ET, and was employed in this study to
ensure diagnostic certainty.
The crude and age-standardized prevalence data
obtained here fall within the range previously reported
from other populations (4.0 – 39.2/1000), but are higher
than the values from earlier studies based in a rural
community in the same ethno-geographical zone, but
published three decades ago by Osuntokun et al. [15].
The earlier study reported a crude prevalence rate(0.1/1000) ten times lower than the present study. Al-
though there is a paucity of comparative data from
other African countries, the studies by Haimanot et al.
[16] (1990) and Dotchin et al. [17] (2008) reported
lower prevalence rates of 5/100,000 and 82/100,000 re-
spectively from communities in Ethiopia and Tanzania
(both in east Africa) respectively. In contrast to these
African studies, our prevalence rates are lower than
that reported from a recent study in Sile, Turkey where
the crude prevalence of ET was documented as 30/
1000 in persons above 18 years of age [23]. It is also
lower than the prevalence rate documented from a
community based study in Manhattan New York [24].
However, direct comparison of these data presupposes
that the population structures of these countries are
similar, and the lack of age-adjustment in the earlier
West African study [25] and that of Haimanot [16] limit
the conclusions that can be derived regarding differences
in prevalence. Though the study by Dotchin et al. [17]
employed age – adjustment this was done to United
Kingdom population of 2001 which may not reflect
WHO new world population.
World-wide, the prevalence of ET varies from not
being present at all [25] to being common [26]. Differ-
ences in prevalence estimates have been attributed to
differences in study design, study population and meth-
odology and diagnostic criteria. Many of the initial stud-
ies on ET prevalence relied on screening instruments
only though in the last two decades most of the popula-
tion studies have incorporated clinical examination.
Other reasons for varied worldwide prevalence could
be differences in exposure to risk and aetiological fac-
tors. Aging is the most consistent documented risk fac-
tor associated with increasing prevalence of ET [27] a
finding also corroborated by this study. Genetics have
also been implicated in ET as demonstrated by clustering
of the condition within families [28]. About a third of
the participants with ET in this study had a positive
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conceivable that undiagnosed ET and recall bias would
have lowered the reporting of a positive family history.
Environmental factors (such as harmane) have been
linked to ET, although the etiologic association is con-
founded by the possibility of a genetic risk modifier [29].
A gender predilection has previously been reported in
some ET studies, while others such as ours have not
found any male to female differences in the prevalence
of ET [4,17]. The basis of a gender predisposition is un-
proven and there are no strong biological indications
that could explain such findings. However, environmen-
tal peculiarities relating to occupational and recreational
exposures differ by gender, and are possible contributors
to gender differences.
The clinical phenotype of ET in this study is consistent
with descriptions from other population-based studies.
The predominant tremor location in our cohort is simi-
lar to previously documented reports with upper limb
tremor being the most common feature. However, com-
pared to other population based studies, none of our
cohort had a head tremor. Dotchin et al. [17] in Tanzania
found head tremor in 54% of their cohort, while Louis
et al. [4] reported head tremor in 27% of their patients.
There are some possible explanations for this discrepancy.
Most importantly, the initial screening questions did not
specifically ask for the presence of head tremor, but rather
hand tremor, and so it is entirely feasible that this inad-
vertently screened out persons with isolated head tremor
as the ET phenotype. However the second screening
questionnaire specifically screened for head tremor in
addition to other tremor locations. This was in addition
to using a face to face examination to ascertain the nature
of the tremor. In this case ascertainment stage, none of
the 36 cases had combined head and hand tremors, all
had hand tremors only. ET can manifest as isolated hand
tremors, isolated head tremors, or a combination of hand
tremors with head tremors. The number of ET cases
encountered was small (36), and mainly of a mild nature
(in about three quarters of the cases) and this could also
partly account for the absence of the concomitant hand
and head tremors. In general, in our clinical practice,
we more commonly encounter isolated hand tremors,
combined hand and head tremors, and less commonly
isolated head tremors, and so our finding may simply be
a reflection of the relative frequencies of these pheno-
types. The higher proportion of mild cases in this study
may indicate the greater likelihood of finding milder, less
disabling ET in the community (in contrast to a clinic-
based study).
We could not assess drug responsiveness in this study
because of the low treatment rate (1/36 only on treat-
ment) and a concomitant large treatment gap in our
cohort with ET. As many as 75 - 99% of patients withET detected through population-based studies are
reported to be previously undiagnosed and untreated
[4,30]. Our findings corroborate the previous documen-
tation of a large treatment gap in ET in the developing
world alluded to in a previous hospital-based study in a
tertiary hospital in Nigeria which highlighted the low
hospital frequency of ET over a 25-year period (only 10
ET cases out of 2.1million patients) and proposed a
probable high treatment gap considering the presump-
tion that ET is a relatively common disorder [31]. Sev-
eral factors including differing severity and impact of ET
on activities of daily living, non-recognition or poor
awareness of ET as a neurological or medical disorder
amenable to treatment, and limited access to care may
contribute to this gap.
We found that a large proportion of ET cases reported
that their tremors began on one side but however did
not find any remarkable gross asymmetry in the tremor
severity in any of the cases on clinical examination, We
suggest that, as often encountered in the clinic setting,
tremors may be more noticeable to patients in the dom-
inant hand despite being present in both hands, because
of the associated interference of tremors with carrying
out actions, and thus attribute this finding to mispercep-
tion of the nature of onset. Furthermore, due to the long
standing nature of ET tremors, historical accounts of site
of onset may not be accurate. Also, although ET is pre-
dominantly regarded as a symmetrical disease, there is
clear evidence that it also presents asymmetrically, and
indeed that mild asymmetry is a fundamental property
of ET [32]. Putzke et al., in a long-term follow-up study,
reported that about 55% of ET cases in their series
presented with asymmetrical disease, and that the
occurrence of asymmetric ET may predict disease pro-
gression [33].
Our study has certain limitations relating to the size of
the population screened and invariably, the population
structure. The population screened (3000) is lower than
that from previous studies, but we anticipate that the
rigorous methodology employed ensured that our data
are credible and truly representative of the current
prevalence of ET in our community. We would have
ideally screened a larger population, but were limited by
the attendant cost implications. The proportions of per-
sons in the age groups is a reflection of the Nigerian
population structure which, according to current official
statistics (2011 estimates), is comprised as follows (com-
bined rural and urban figures): <15 years (40.9%), 15 –
64 years (55.9%), 65 years and above (3.1%), and median
age (19.2 years) [34]. Our study was conducted in an
urban centre and the smaller percentage of urban-
dwelling elderly (>65 years – 2.2%) is expected. We how-
ever provide age adjustment to the WHO New World
population and complete data for adjustment to any
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ings with those of other researchers. Finally, we note the
possibility of persons with very mild tremors having
screened negative in the initial stage if the tremors were
not obvious to the participants themselves.
Conclusions
We conclude that ET is a common disorder in the urban
Nigerian population studied here, and the clinical pheno-
type is similar to that previously described by other
researchers. Improved public awareness and physician edu-
cation will ensure that ET is recognized, and treatment
offered where appropriate.
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